Author Manuscript Published OnlineFirst on April 7, 2020; DOI: 10.1158/0008-5472.CAN-19-3018 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Moshkovich et al. PADI4 negatively regulates breast cancer stem cells Peptidylarginine deiminase IV (PADI4) regulates breast cancer stem cells via a novel tumor cell-autonomous suppressor role by Nellie Moshkovich1, Humberto J. Ochoa1, Binwu Tang1, Howard H. Yang1, Yuan Yang1, Jing Huang1, Maxwell P. Lee1 and Lalage M. Wakefield1 1Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda MD 20892, USA Running title: PADI4 negatively regulates breast cancer stem cells Keywords: PADI4, Cancer stem cells, Breast cancer, Citrullination, Epigenetics Financial support: This work was supported by funding from the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH project ZIA BC 005785. Corresponding author: Lalage M. Wakefield D Phil, ORCID ID# 0000-0003-4124-5250 37 Convent Drive, MSC 4255, National Cancer Institute, Building 37, Room 4032A, Bethesda MD 20892-4255 Tel: 240-760-6808 Email:
[email protected] Conflict of interest statement: The authors declare no conflicts of interest. Word count: Abstract: 240 Main text: 5772 (excluding acknowledgments, references and figure legends) Number of Figures: 5 Number of Tables: 1 Number of References: 49 1 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 2020 American Association for Cancer Research. Author Manuscript Published OnlineFirst on April 7, 2020; DOI: 10.1158/0008-5472.CAN-19-3018 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.